Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02989155 · ClinicalTrials.gov registry record

Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty

A clinical trial, sponsored by Ohio State University.

Completed
Registry status
576
Enrollment target

NCT02989155 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 576 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02989155 has completed, sponsored by Ohio State University.

COMPLETED
Registry status
576 participants
Enrollment target

Study Summary

The purpose of this study is to determine the need for a blood transfusion during surgery and to evaluate the levels of certain proteins in the blood when given tranexamic acid.

Trial Details

FieldValue
Enrollment Target 576 participants
Start Date 2016-01
Est. Completion 2016-12

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT02989155

The ClinicalTrials.gov registry entry for NCT02989155 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 576 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02989155 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02989155 about?

NCT02989155 is a clinical study titled "Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty". The purpose of this study is to determine the need for a blood transfusion during surgery and to evaluate the levels of certain proteins in the blood when given tranexamic acid.

What is the current status of trial NCT02989155?

This trial is currently completed. The enrollment target is 576 participants. The study started on 2016-01. Estimated completion is 2016-12.

Who is sponsoring clinical trial NCT02989155?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.